iVC—It’s Beyond Vitamin C, According to Seiwa Kasei

11.10.21

Visit booth 855 to learn more about this stable derivation of vitamin C.

Seiwa Kasei (booth 855) is promoting iVC, a high value-added vitamin C derivative developed by fusion of vitamin C and glycerin. iVC is developed by the derivatization of vitamin C, which, under normal circumstances, easily degrades in the presence of oxygen. According to Seiwa Kasei, this novel derivative results in high stability and simple formulation of cosmetics.

The material has biological activities such as melanin inhibition and collagen production As well as unique functions that have not yet been seen on existing vitamin C derivatives.
iVC, according to the company. Seiwa Kasei will be represented by Rita Corp at NYSCC Suppliers’ Day in booth #855.

More info: Seiwa Kasei Co., Ltd., Email: sales@seiwakasei.co.jp; Website: https://seiwakasei.jp/ivc/en/